Transcultural translation-adaptation to Spanish of the Infants’ Dermatitis Quality of Life questionnaire for children under four years with atopic dermatitis
PDF (Spanish)
PubMed

Supplementary Files

HTML (Spanish)

Keywords

Quality of life
Atopic dermatitis
Child

Abstract

Background: Atopic dermatitis is observed in up to 20% of children, hence the importance of tools to support its evaluation.

Objective: To determine the validity and reliability of the Spanish adaptation of the IDQOL questionnaire in patients <4 years of age with atopic dermatitis (AD).

Methods: Translation and back-translation of the questionnaire; a pilot test was done in 30 children with AD to arrive at a final version. Internal reliability (Cronbach’s alpha) and correlation of IDQOL and SCORAD scores (Pearson correlation coefficient) were measured.

Results: 102 children aged between two and 48 months were included. The Pearson correlation coefficient (r) of IDQOL and SCORAD scores was 0.697 (p = 0.0001), indicating a high positive correlation. The correlation between the severity measured by the caregiver and the SCORAD score (r = 0.565, p = 0.0001) proved to be low positive. The internal consistency of IDQOL using Cronbach’s alpha was 0.84, indicating good consistency of the instrument for assessing quality of life.

Conclusion: The IDQOL questionnaire in Spanish is a valid measure of quality of life in patients < 4 years with AD and is useful in monitoring and in clinical trials.

PDF (Spanish)
PubMed

References

Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003;148 Suppl 63:3-10.

DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012;33(3):227-234. doi: 10.2500/aap.2012.33.3569.

Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: Data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67-73. doi: 10.1038/jid.2010.251.

Bieber T. Atopic dermatitis. New England J Med 2008; 358:1483-1494. doi: 10.5021/ad.2010.22.2.125

Garnacho-Saucedo G, Salido-Vallejo R, Moreno-Giménez JC. Actualización en dermatitis atópica. Propuesta de algoritmo de actuación. Actas Dermosifiliogr. 2013;104(1):4-16. doi: 10.1016/j.ad.2011.12.008

Wen HJ, Chen PC, Chiang TL, Lin SJ, Chuang YL, Guo YL. Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors. Br J Dermatol. 2009;161:1166-1172. doi: 10.1111/j.1365-2133.2009.09412.x

Álvarez GK, Delgado CA, Naranjo FJA, Pérez MM, Valdés del Pino AM. Dermatitis atópica en un infante. MEDISAN 2014;18(1):120-126.

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol, 2014;70(2):338-348. doi: 10.1016/j.jaad.2013.10.010

Civelek E, Sahiner UM, Yüksel H, Boz AB, Orhan F, Uner A, et al. Prevalence, burden, and risk factors of atopic eczema in school children aged 10-11 years: A national multicenter study. J Invest Allergol Clin Immunol. 2011;21:270-277.

Al Shobaili HA. The impact of childhood atopic dermatitis on the patients’ family. Pediatr Dermatol. 2010;27(6):618-623. doi: 10.1111/j.1525-1470.2010.01215.x.

Sánchez-Pérez J, Daudén-Tello E, Mora AM, Lara Surinyac N. Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study. Actas Dermosifiliogr. 2013;104(1):44-52. doi: 10.1016/j.ad.2012.03.008

Conde-Taboada A, González-Barcala FJ, Toribio J. Dermatitis atópica infantil: revisión y actualización. Actas Dermosifiliogr. 2008;99:690-700.

Basra MK, Gada V, Ungaro S, Finlay AY, Salek SM. Infants’ Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. Br J Dermatol. 2013;169(4):760-768. doi: 10.1111/bjd.12563

Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2016 Revista Alergia México

Downloads

Download data is not yet available.